Reportedly, Johnson & Johnson (JNJ) announced to host a conference call for investors at 8:30 a.m. on Tuesday, October 19th to review and analyze third-quarter results. The call will be hosted by Executive Vice President and Chief Financial Officer, Joseph J. Wolk. Teh. The senior leadership will take care of the question and answer portion of the call. A replay of the webcast will be available three hours after the conference call ends. The necessary information can be reached on the company’s website.
Dial-in details:
Interested parties can dial 877-869-3847 for the U.S and participants outside the U.S can dial the number 201-689-8261. A replay of the conference call (available approximately until noon on November 2nd), parties can dial in 877-660-6853 for (U.S) & 201-612-7415 (outside the U.S). 13722724 is the replay conference ID number for all callers.
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare-focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.
